Viewing Study NCT00176592


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2026-01-29 @ 3:45 AM
Study NCT ID: NCT00176592
Status: COMPLETED
Last Update Posted: 2021-11-16
First Post: 2005-09-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI
Sponsor: University of Medicine and Dentistry of New Jersey
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Sclerosis View
None Brain View
None Betaseron View
None Copaxone View
None MRI View